Lieutenant Colonel Mara Kreishman-Deitrick, Ph.D.
U.S. Army Medical Materiel Development Activity
Mara Kreishman-Deitrick, Ph.D.,
Lieutenant Colonel Mara Kreishman-Deitrick is currently serving as Deputy Commander of the U.S. Army Medical Materiel Development Activity, a subordinate command of the U.S. Army Medical Research and Development Command at Fort Detrick, Maryland. Kreishman-Deitrick received her Ph.D. in Biological Chemistry from the University of Texas Southwestern Medical Center at Dallas in 2004, and her Bachelor of Science in Biochemistry from the University of Cincinnati in 1998. Her military education and training includes the Army Medical Department Officer Basic Course and Captains' Career Course, the Army Command and General Staff College Intermediate Level Education Course. She is Level 3 certified in Science and Technology Management and Program Management by the Defense Acquisition University, and holds Regulatory Affairs Certification in the United States.
Kreishman-Deitrick entered active duty as a 71B Medical Service Corps Biochemist upon completion of her Ph.D. in 2004. Her first assignment was in the Department of Medicinal Chemistry, Division of Experimental Therapeutics at the Walter Reed Army Institute of Research, Silver Spring, Maryland, where she served as a Principal Investigator and Chief of Nuclear Magnetic Resonance Spectroscopy from 2004 to 2006. Her scientific focus was on structure-based design of new antimalarial drugs. In 2006, Kreishman-Deitrick was named WRAIR Headquarters Company Commander, serving in this role until 2008. For the next five years, she served as a Chartered Product Manager for advanced development of multiple antiparasitic drugs and diagnostics in the Pharmaceutical Systems Project Management Office at USAMMDA. In 2013, Kreishman-Deitrick was selected for the competitive Army Medical Department Long-Term Health Education and Training Fellowship at the U.S. Food and Drug Administration, where she trained as a Reviewer in both the Division of Anti-infective Products and the Office of Counterterrorism and Emergency Coordination in the Center for Drug Evaluation and Research. Kreishman-Deitrick was then assigned to the Experimental Therapeutics Branch at WRAIR from 2014 to 2020, where she progressed from Department Chief for Drug Development to Deputy Branch Director, to Branch Director in 2016. Experimental Therapeutics is the DOD's "bench to bedside" drug discovery and development enterprise, housing a robust pipeline of new drugs being developed to prevent and treat malaria, leishmaniasis and antibiotic-resistant bacterial infections. The capabilities of Experimental Therapeutics span all aspects of chemistry, and in vitro and in vivo biological test systems to support small molecule drug discovery through early clinical development. Kreishman-Deitrick also served as the Chair of the Next Generation Malaria Drug Integrated Product Team, and as the Capability Area Manager for Antiparasitic Drugs for the Military Infectious Diseases Research Program. She moved to USAMMDA in July 2020, where she assumed the role of Deputy Commander. In this role, Kreishman-Deitrick is responsible for the daily operations of a team of 300 personnel, execution of a $350 million annual budget, and support and execution of USAMMDA's mission to develop and field medical solutions for the Warfighter. USAMMDA delivers products through five Project Management Offices, spanning all battlefield medical threats and requirements.
Kreishman-Deitrick has co-authored 21 peer-reviewed publications, and given multiple invited lectures. Her awards and decorations include the Meritorious Service Medal (2OLC), Army Commendation Medal (1OLC), Army Achievement Medal (1OLC), and the U.S. Army Medical Service Corps Carmack Medal, and she is an active member of the American Society for Tropical Medicine and Hygiene. Kreishman-Deitrick is a member of the Order of Military Medical Merit, and was awarded the 2019 Undersecretary of Defense for Acquisition and Sustainment Acquisition Workforce Award for Individual Achievement in Science and Technology Management.